quite a few providers have published studies of utilizing the RMCE system to produce monoclonal antibodies. In 2013, Genentech founded a CRE dependent monoclonal antibody expression System for RMCE by screening transcriptional active sites while in the CHO genome (Crawford et al., 2013). Inserting just one expression cassette with weighty and light